D9-Tetrahydrocannabinol (THC) – Page 2 – Medical Marijuana

Neuroprotection by D9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity

Marijuana, Tetrahydrocannabinol, and Pulmonary Antibacterial Defenses

Long-term behavioral and biochemical effects of an ultra-low dose of D9-tetrahydrocannabinol (THC)- neuroprotection and ERK signaling

Influence of Treatment of Tourette Syndrome with D9-Tetrahydrocannabinol (D9-THC) on Neuropsychological Performance

Histone Modifications Are Associated with Delta (9)-tetrahydrocannabinol-Mediated Alterations in Antigen-Specific T Cell Responses

Fatty Acid Binding Proteins (FABPs) are Intracellular Carriers for D9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

Effect of D-9-Tetrahydrocannabinol and Cannabidiol on Nocturnal Sleep and Early-Morning Behavior in Young Adults

Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol

D9-Tetrahydrocannabinol Prevents Methamphetamine-Induced Neurotoxicity

Cannabidiol Enhances the Inhibitory Effects of D9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival